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Human complement component C3 has been cleaved completely by trypsin in the presence of 2-propanol. 
The hydrolysate was fully solubilized and fractionated by reversed-phase HPLC. Two peptides only con- 
tained glucosamine, Unambiguous sequence anafyses identified Asn-63 of the #?-chain and Asn-268 of the 
a-chain as the sites of carbohydrate attachment. A third potential Asn-Xaa-Thr/Ser glycosylation site, Asn- 
946 of the a-chain, is not modified. The different states of glycosylation of the three sites cannot be explained 
by differences in exposure or secondary structure. All three are predicted reverse turn. 
Glycosylation Amino acid sequence Complement component C3 Trypsin 2-Propanol 
1. INTRODUCTION 
Complement component C3 is a central effector 
molecule in the complement cascade f 11. Human 
C3 is a glycoprotein of M, 187 500. The biologically 
active molecule is composed of two disulfide- 
linked chains. The &chain comprises 645 residues 
and the a-chain 992 residues. The complete cDNA 
sequence coding for human prepro-C3 was recent- 
ly determined by De Bruijn and Fey [2]. The 
molecule is post-translationally modified by 
removal of the 2Zresidue signal peptide that 
precedes the &chain, and the four arginine 
residues that connect the P-chain and a-chain. 
Thirteen disulfide bonds and a functionally impor- 
tant thioester bond are formed (review [2]). Fur- 
thermore, two high mannose-type oligosaccharides 
are attached, one to each chain [3]. The cDNA 
derived amino acid sequence predicts a maximum 
of three N-glycosylation sites [2], whereas elec- 
trophoretic separation of C3 fragments followed 
by staining for carbohydrate restricts glycosylation 
sites to a 17 kDa fragment of the P-chain [4] and 
a 26 kDa fragment of the a-chain [4-61. 
Here we show by sequence analysis that Asn-63 
of the P-chain and Asn-268 of the a-chain are the 
only sites of N-glycosylation in human comple- 
ment component C3. We have used a 1: 1 mixture 
of the two common genetic variants C3 S and C3 
F in the experiments and have no indication that 
they differ in this respect. The carbohydrate chains 
of human C3 play no known physioIogica1 role. 
2. MATERIALS AND METHODS 
Active human complement component C3 S and 
C3 F in a 1: 1 mixture was kindly donated by N. 
Behrendt. It was purified and characterized as 
described [7], and stored at - 80°C as pellets con- 
taining 2.5010 C3 in 20 mM KHzPOd, 150 mM 
NaCl, pH 7.4. Digestions of 1% C3 solutions were 
brought about at 37°C under nitrogen or argon. 
AnaIytical tryptic digestions of C3 samples 
denatured to different extents were carried out 
overnight with E : S ratios (enzyme: substrate) of 
1: 20 mol/mol. Samples in buffer, in 0.2% SDS, in 
15% and in 22.5% 2-propanol were preincubated 
at 60°C for 10 min in one series of experiments 
and untreated in a parallel series before the addi- 
tion of trypsin. For preparative purposes 90 nmol 
C3 was titrated to pH 8.0 with 0.25 M NaOH and 
preincubated in 15% 2-propanol at 60°C for 
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10 min. The sample became milky. Trypsin 
(trypsin-TPCK, Worthington) in 10 mM CaC12 
was added twice, at zero time and after 6 h, giving 
a final E : S = 1 : 10 mol/mol. The clear but highly 
viscous digest was centrifuged after 22 h. The gel- 
like precipitate ‘melted’ on addition of 50 ~1 10% 
SDS. The supernatant and dissolved gel were frac- 
tionated separately by reversed phase-high perfor- 
mance liquid chromatography (RP-HPLC). 3% of 
each fraction was subjected to amino acid analysis. 
Peptic digestion of C3 was carried out at E:S = 
1: 30 in 5% HCOOH for 24 h. Thermolytic diges- 
tion of methylamine-inactivated C3 at E : S = 1 : 40 
was stopped after 4 h. The completeness of all 
digestions was evaluated by SDS-PAGE 
(polyacrylamide gel electrophoresis) in 15% gels 
P31. 
All peptide separations were accomplished on a 
7.8 x 180 mm column of Nucleosil 5 Cl8 
(Macherey-Nagel), except hat the SDS solubilized, 
gel-like, tryptic peptides were fractionated on a 
4.6 x 125 mm column of Nucleosil 300-5 C4. Col- 
umns were packed in the laboratory. A 2 ml sam- 
ple loop was used. 
Amino acid analyses were performed on HPLC 
equipment (Waters) with post-column derivatiza- 
tion by o-phthalaldehyde in non-halide buffers. 
Glucosamine appears as a broad peak after 
phenylalanine. Hydrolysis was accomplished in the 
vapor of 6 M HCl at 108”C, for 6 h to detect 
glucosamine, and for 20 h to determine amino acid 
compositions. Amino acid sequence analyses were 
carried out on a gas-phase sequencer (model 470A, 
Applied Biosystems) using the program 02NRUN. 
PTH-amino acids generated by the sequencer were 
analysed by HPLC equipment (Waters) with 254 
and 313 nm detectors on a 4.6 x 125 mm column 
of Spherisorb SS-ODS 2 (Phase Sep) [9]. 
3. RESULTS 
3.1. Tryptic digestion 
SDS-PAGE evaluation of the analytical tryptic 
digestions of human complement component C3 
showed that samples preincubated at 60°C were 
the most degraded, but that only the preincubated, 
2-propanol containing samples were completely 
digested. In the preparative experiment neither the 
supernatant nor the gel-like precipitate showed 
bands of high molecular mass, only diffuse 
A227 - 
A280 --- 
Fig. 1. Isolation of tryptic glycopeptides 1G and 2G by RP-HPLC. A 7.8 x 180 mm column of Nucleosil Cl8 was eluted 
by a 1 h linear gradient of 5-70% 2-propanol in 0.1% TFA at a flow rate of 1 ml/min. The fraction size was 0.5 ml. 
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a number of stable structural domains which also 
in our experiments prove to be very resistant to 
complete proteolytic digestion. Here we show that 
preincubation at 60°C for 10 min followed by 
tryptic digestion of C3 in 15% 2-propanol gives 
complete and specific cleavage judging from SDS- 
PAGE and sequence analyses. 
Analysis of the carbohydrate composition in 
human complement components howed that only 
N-acetylglucosamine and mannose are present in 
C3 [lo]. Hase et al. [3] have solved the covalent 
structure of the carbohydrate side chains of human 
C3 after release by hydrazinolysis. They found that 
the a-chain contains mainly Mans(GlcNAc)z and 
Mang(GlcNAc)z, while the&chain contains mainly 
Mans(GlcNAc)z and Mans(GlcNAc)z. These com- 
positions were recently confirmed by Hirani et al. 
[l l] by compositional analysis of sugar chains 
released by endo-fl-N-acetylglucosamidase H. 
We have isolated and sequenced all 
glucosamine-containing tryptic peptides from 
human complement component C3. Our results 
fully confirm the recent cDNA derived amino acid 
sequence of human C3 [2]. The sequence of the 
tryptic glycopeptide 2G is identical to residues 
74-94 of prepro-C3, and 1G to residues 938-940. 
Asn-85, Asn-939 and Asn-1617 are potential N- 
glycosylation sites in prepro-C3. We prove that the 
residues corresponding to Asn-85 and Asn-939 are 
indeed glycosylated in C3, and we find only these 
two sites. These results are in agreement with the 
results of carbohydrate staining of the C3 
fragments mentioned in section 1. 
The observed pattern of glycosylation in human 
complement component C3 raises the question 
why Asn-268 of the a-chain carries more mannose 
residues than Asn-63 of the P-chain, and why 
Asn-946 of the a-chain is unmodified. Aubert et 
al. [ 121 and Beeley [ 131 showed that N-glycosylated 
sites are nearly always exposed turns or loops and 
that most sites are predicted reverse turns. Sec- 
ondary structure prediction for C3 by the method 
of Chou and Fasman [14] predicts that all three 
asparagine residues are part of reverse turns. In the 
sequence of post translational N-glycosylation 
events (review [ 151) attachment of oligosaccharide 
is followed by sequential removal of the three 
glucose residues and the four a-l,2 linked mannose 
residues. Therefore, we may expect that Asn-63 of 
the/?-chain, which is the most processed as it binds 
62 
5-6 mannose residues only, is also the most ex- 
posed, and that the unprocessed a-chain Asn-946 
is the least exposed among the three. Evaluation of 
the exposure of the three asparagine residues by 
the hydropathic index [16] averaged over the 
seven-residue peptide with asparagine centrally 
suggests the exactly opposite order of exposure and 
comes to - 0.4 for Asn-946 and - 0.3 for Asn-268 
of the a-chain, and +0.2 for Asn-63 of the & 
chain. Consequently, the answer might await the 
appearance of the spatial structure of C3 or might 
be sought in an unrecognized glycosylation 
requirement. 
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